EpiCypher
PrivateLast Round
Seed
Jul 1, 2024
Total Funding Raised
$9.11M
Company Overview
EpiCypher operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Seed round in July 2024.
EpiCypher is a biotechnology company that develops and sells reagents, kits, and services for epigenetics and chromatin biology research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2G
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpiCypher Comparables
Compare EpiCypher with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Active Motif | 85% | |
| Epigentek Group Inc. | 79% | |
| Hologic, Inc. | 78% |
For institutional investors. Book with your work email.
EpiCypher Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 1, 2024 | ||||
| Grant | Aug 18, 2022 | ||||
| Accelerator | Oct 15, 2021 | ||||
| Grant | May 6, 2014 |
For institutional investors. Book with your work email.
EpiCypher Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| BioTools Innovator | Accelerator |
| BroadOak Capital Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Monthly visitors increased 43% MoM, reaching 32.6K.
- Nov 11, 2025
Launched the Fiber-seq Kit for single-molecule chromatin mapping.
For institutional investors. Book with your work email.
EpiCypher Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EpiCypher's valuation, stock price, and market status.
Is EpiCypher a public or private company?
EpiCypher is a private company.
What is the current stock price of EpiCypher?
EpiCypher is a private company, so its shares have no public market price. Caplight tracks EpiCypher's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EpiCypher worth (valuation)?
Valuation information for EpiCypher is not publicly available.
Can I buy EpiCypher stock?
EpiCypher shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EpiCypher's last funding round?
EpiCypher's most recent funding round was Seed on July 1, 2024.
Who are the main investors in EpiCypher?
Key investors in EpiCypher include NIH RADx, BioTools Innovator, BroadOak Capital Partners.
Will EpiCypher IPO soon?
No public IPO plans have been announced for EpiCypher.
How can I track EpiCypher secondary market activity?
Caplight tracks bids, offers, and trades in EpiCypher's shares on secondary markets.